Ludwig Cancer Research

Newswise: 66c8e1f712376_Screenshot2024-08-23150103.png

A switch for immune memory and anti-tumor immunity

A Ludwig Cancer Research study has identified a metabolic switch in the immune system’s T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and a T cell subtype found...
23-Aug-2024 3:05 PM EDT Add to Favorites

Newswise: 665dfd68a9b9c_Screenshot2024-06-03130831.png

Two-pronged attack strategy boosts immunotherapy in preclinical studies

A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system’s ability to target and eliminate cancer cells.
3-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 663a47cec0777_Screenshot2024-05-07111207.png

AI predicts tumor-killing cells with high accuracy

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.
7-May-2024 10:05 AM EDT Add to Favorites

Newswise: 66292d957d3ed_Screenshot2024-04-24115249.png

Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack

A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines the anti-cancer immune response and compromises a recently approved immunotherapy known as adoptive cell therapy (ACT) using tumor...
24-Apr-2024 11:05 AM EDT Add to Favorites

Newswise: 65c267e49b9a2_Screenshot2024-02-06115629.png

Immune networks in tumors prime responses to a personalized immunotherapy

Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a...
6-Feb-2024 11:05 AM EST Add to Favorites

Newswise: 65b7f031f1cff_Screenshot2024-01-29133605.png

Immunologist Lydia Lynch appointed member of Ludwig Princeton

It is with great pleasure that we announce the appointment of Lydia Lynch as a full member of the Princeton Branch of the Ludwig Institute for Cancer Research.
29-Jan-2024 1:05 PM EST Add to Favorites

Newswise: 65a95dceeaf75_Screenshot2024-01-18114300.png

Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more

A Ludwig Cancer Research study has generated a granular portrait of how the cellular and molecular components of the blood vessels that feed brain metastases of melanoma and lung and breast cancers differ from those of healthy brain tissue,...
18-Jan-2024 12:05 PM EST Add to Favorites